News

A new drug developed by researchers at the University of East Anglia has been shown to be effective against all of the main subtypes of primary bone cancer.

A new study has indicated that reducing the methylation of a key messenger RNA can promote macrophage migration into the brain and improve the symptoms of Alzheimer's disease.

A drug commonly used to treat symptoms of Alzheimer’s disease could reduce symptoms of adults who experience compulsive hair-pulling and skin-picking.

A Phase 1 trial of a temperature-stable TB vaccine has shown that it is both safe and stimulates an immune response in healthy adults.

Scientists have developed a potential new treatment for autoimmune encephalitis, a condition described as a "fire in the brain" by patients.

Research involving a cell "squeezing" process has shown promising results in a trial for the treatment of a subtype of HPV16-driven head and neck cancer.

A new system that uses light to help transport drugs into cells has been developed and has been shown to effectively deliver drugs to target cells.

A new analysis of 180 indigenous Africans from a dozen ethnically, culturally, geographically, and linguistically varied populations by an international scientific team offers new insights into human history and biology, and may inform precision medicine approaches of the future.

Researchers have identified a possible treatment strategy for a rare bone marrow failure syndrome that is named poikiloderma with neutropenia.

Researchers have developed a new drug delivery approach that uses nanoparticles to enable more effective and targeted delivery of anti-cancer drugs to treat brain tumors in children.